Calliditas Therapeutics Q1 EPS $(0.88) Down From $(0.33) YoY, Sales $28.43M Up From $18.32M YoY
Calliditas Therapeutics Q1 EPS $(0.88) Down From $(0.33) YoY, Sales $28.43M Up From $18.32M YoY
Calliditas Therapeutics第一季度每股收益爲0.88美元（0.88美元），低於同比0.33美元，銷售額爲2843萬美元，高於同比1,832萬美元
Calliditas Therapeutics (NASDAQ:CALT) reported quarterly losses of $(0.88) per share. This is a 163.47 percent decrease over losses of $(0.33) per share from the same period last year. The company reported $28.43 million in sales this quarter. This is a 55.21 percent increase over sales of $18.32 million the same period last year.
Calliditas Therapeutics（納斯達克股票代碼：CALT）公佈的季度虧損爲每股0.88美元。與去年同期每股虧損0.33美元（0.33美元）相比，下降了163.47％。該公司報告本季度銷售額爲2843萬美元。這比去年同期的1,832萬美元的銷售額增長了55.21％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。